These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042 [TBL] [Abstract][Full Text] [Related]
23. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Tajima H; Matsumoto K; Nakamura T Exp Cell Res; 1992 Oct; 202(2):423-31. PubMed ID: 1327854 [TBL] [Abstract][Full Text] [Related]
24. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Comoglio PM EXS; 1993; 65():131-65. PubMed ID: 8380735 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
26. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor. Zlot C; Ingle G; Hongo J; Yang S; Sheng Z; Schwall R; Paoni N; Wang F; Peale FV; Gerritsen ME J Biol Chem; 2003 Nov; 278(48):47654-9. PubMed ID: 14500721 [TBL] [Abstract][Full Text] [Related]
27. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808 [TBL] [Abstract][Full Text] [Related]
28. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641 [TBL] [Abstract][Full Text] [Related]
29. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403 [TBL] [Abstract][Full Text] [Related]
30. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846 [TBL] [Abstract][Full Text] [Related]
31. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669 [TBL] [Abstract][Full Text] [Related]
33. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639 [TBL] [Abstract][Full Text] [Related]
34. Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner. Crostella L; Lidder S; Williams R; Skouteris GG Oncogene; 2001 Jun; 20(28):3735-45. PubMed ID: 11439336 [TBL] [Abstract][Full Text] [Related]
35. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069 [TBL] [Abstract][Full Text] [Related]
36. Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. Dai Y; Siemann DW BMC Cancer; 2012 May; 12():198. PubMed ID: 22639908 [TBL] [Abstract][Full Text] [Related]
37. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459 [TBL] [Abstract][Full Text] [Related]
38. Differentiating and proliferative effects of HGF in renal proximal tubular cells are mediated via different signalling pathways. Stracke S; Ernst F; Jehle DR; Grunewald RW; Haller H; Keller F; Jehle PM Nephrol Dial Transplant; 1998 Jun; 13(6):1398-405. PubMed ID: 9641168 [TBL] [Abstract][Full Text] [Related]
39. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
40. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK; Muller WJ Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]